Radiation Therapy Delivery Challenges in Older Patients During Coronavirus Disease 2019 Pandemic.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 27 09 2020
revised: 02 11 2020
accepted: 11 11 2020
pubmed: 15 12 2020
medline: 15 12 2020
entrez: 14 12 2020
Statut: ppublish

Résumé

The management of older patients in radiation therapy (RT) departments has been challenging in the context of the Coronavirus Disease 2019 (COVID-19) outbreak. We report our experience of RT adapted schedules or strategy changes in older patients during the COVID-19 pandemic. Patients aged ≥75 years were recruited during weekly chart rounds. All were potentially eligible for a specific intervention to reduce the frequency of patients' visits to the hospital. The effect of deferring radiation and hypofractionation of RT schedules was assessed in terms of the number of courses initially planned and replanned during the lockdown. Twenty patients were identified during the official lockdown in France (March 17 to May 11). Median age was 78 years (75-95 years). Most patients were male (n = 12, 60%) being treated in the postoperative setting (n = 17, 85%). RT was delayed in 11 cases (55%) with hormonal therapy prescribed in 10 cases (50%). Altered RT fractionation was proposed for 5 cases (25%); combinations of altered fractionation and deferral of radiation were applied in 3 cases (15%). The number of radiation courses initially planned and replanned according to the pandemic context: 563 and 197, respectively (-62%; In the context of the COVID-19 outbreak, individual risk-based radiation therapy seems to be safe. Systematic screening of patients for COVID-19 before starting radiation therapy is mandatory. In our department the oncogeriatrics expertise availability for daily practice was of great use during the pandemic. Other prospective studies are needed to validate such strategies in case of resurgence of similar outbreaks.

Identifiants

pubmed: 33313442
doi: 10.1016/j.adro.2020.11.011
pii: S2452-1094(20)30356-0
pmc: PMC7718104
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100626

Informations de copyright

© 2020 The Author(s).

Références

Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281
pubmed: 32241520
Adv Radiat Oncol. 2020 Apr 01;5(4):659-665
pubmed: 32292839
Lancet Oncol. 2020 May;21(5):619-621
pubmed: 32220659
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Clin Transl Radiat Oncol. 2020 Mar 24;22:55-68
pubmed: 32274425
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Adv Radiat Oncol. 2020 May 27;5(4):644-650
pubmed: 32775775
Cancers (Basel). 2020 May 19;12(5):
pubmed: 32438703
Am J Prev Med. 2007 Sep;33(3):222-49
pubmed: 17826584
J Geriatr Oncol. 2020 Jun;11(5):747-749
pubmed: 32273247
J Geriatr Oncol. 2020 Nov;11(8):1190-1198
pubmed: 32709495
Eur J Cancer. 2020 Aug;135:130-146
pubmed: 32580130

Auteurs

Mohamed Aziz Cherif (MA)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.
Association of Radiation therapy and Oncology of the Mediterranean Area and Transatlantic Radiation Oncology Network.

Gokoulakrichenane Loganadane (G)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.

Kamel Debbi (K)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.

Gabriele Coraggio (G)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.
Association of Radiation therapy and Oncology of the Mediterranean Area and Transatlantic Radiation Oncology Network.

Sahar Ghith (S)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.

Asma Hadhri (A)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.

Wissal Hassani (W)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.

Noémie Grellier (N)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.
Association of Radiation therapy and Oncology of the Mediterranean Area and Transatlantic Radiation Oncology Network.

Nhu Hanh To (NH)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.
INSERM Unit 955; Team 21, IMRB, University of Paris-Est (UPEC), Creteil, France.

Yazid Belkacemi (Y)

AP-HP, Department of Radiation Oncology and Henri Mondor Breast Center, University of Paris-Est (UPEC), Creteil, France.
Association of Radiation therapy and Oncology of the Mediterranean Area and Transatlantic Radiation Oncology Network.
INSERM Unit 955; Team 21, IMRB, University of Paris-Est (UPEC), Creteil, France.

Classifications MeSH